| http://www.w3.org/ns/prov#value | - The other initial target for CSF-1 therapy was fungal diseases, where CSF-1???stimulated macrophages were purported to phagocytose organisms, such as Candida.77 There was no reported follow-up from the initial clinical studies in humans that suggested an increase in survival rate of bone marrow transplant patients with disseminated candidiasis78; it is not known whether this was the result of a la
|
